Voltron Therapeutics

About:

Voltron Therapeutics develops precision-guided, self-assembling vaccines for cancer and infectious diseases.

Top Investors: U.S. Department of Defense

Description:

Voltron Therapeutics is a Delaware corporation that specializes in cell-mediated responses. It develops precision-guided, self-assembling vaccines for cancer and infectious diseases.

Total Funding Amount:

$5.88M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-08-17

IPO Status:

Private

Industries: